2016-11-02 14:58:28 UTC

AGA Members Take Center Stage at UEG Week 2016

Nov. 2, 2016

The Best of DDW® and Rising Stars sessions at the October conference highlighted a number of AGA members and their research.

AGA leaders in their respective fields attended the recent UEG Week in Vienna, Austria. There was a record attendance of 13,300 with delegates from around the world. AGA members were highlighted in the "Best of Digestive Disease Week® (DDW) " session, which saw more than 1,000 attendees.

AGA President Timothy Wang, MD, AGAF, co-chaired the session along with UEG President Michael P. Manns, MD. Other AGA speakers included:

  • C. Richard Boland, MD, AGAF: GI Oncology
  • Robert J. Fontana, MD: Liver
  • Stuart J. Spechler, MD, AGAF: Esophagus and Upper GI
  • Santhi Swaroop Vege, MD, AGAF: Pancreatic Disorders
  • AGA Education and Training Councillor Deborah D. Proctor, MD: IBD

Additionally, in the "Rising Stars from Europe and the USA'" session — co-chaired by Dr. Proctor and UEG Representative Luigi Riccardiello, MD — AGA Research Scholar Award holder Kyle Staller, MD, and UEG Rising Star 2016 Mira Wouters, MD, of Belgium discussed their latest research into the epidemiology and pathogenesis of irritable bowel syndrome (IBS).

Dr. Staller spoke about his ongoing research identifying adolescent dietary and lifestyle risk factors that play a role in the development of IBS in adulthood, potentially identifying adolescents at risk for IBS to be targeted for lifestyle interventions.

More on Barrett's Esophagus

Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and Differentiation

Oct. 22, 2017

We describe a novel porcine 3-dimensional culture model that reproduces esophageal submucosal gland proliferation in vivo associated with cancer and injury.

Late Recurrence of Barrett’s Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial

Sept. 1, 2017

Endoscopic surveillance of patients with BE treated with radiofrequency ablation will likely be of diminishing value as the time since ablation grows.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device

Sept. 1, 2017

We found Cytosponge screening with endoscopic confirmation to be a cost-effective strategy.